13F

Position

S.E.E.D. Planning Group LLC in Arcutis Biotherapeutics, Inc.

Back to the book · All holders of ARQT

Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.

QuarterSharesValueImplied pxEst. markFlowWeight
Q4 202513K$377.5K0.1%